Should British American Tobacco plc And Imperial Tobacco Group PLC Shareholders Be Worried By A $24bn Damages Award?

No grounds for complacency at British American Tobacco plc (LON:BATS) and Imperial Tobacco Group PLC (LON:IMT)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

british american tobacco / imperial tobaccoNews that a Florida court has awarded $23.6bn to the widow of a smoker who died of lung cancer might have caused some spluttering in the boardrooms of both BAT (LSE: BATS) and Imperial Tobacco (LSE: IMT) . The award — mainly punitive damages — was made against US tobacco giant Reynolds America.

BAT is directly affected: it owns 42% of Reynolds, and is about to pump another $5bn of cash into the company to maintain its shareholding after Reynolds acquires rival Lorillard. Meanwhile, Imperial is spending $7bn to acquire brands being shed as a result of the deal. Those assets come with indemnities against health-related litigation, but being propelled from number 5 to number 3 in the market will surely put Imperial more in the firing line of future litigation. BP and the banks are testimony that US courts are unsympathetic to foreign firms.

Whatever the boardroom reaction, investors seem to have shrugged it off with the shares of both BAT and Imperial just down a percent or two. The expectation is that such a massive award will be slashed on appeal. Its constitutional basis is suspect, and the tobacco industry has seen this before: in 2002 a Los Angeles court imposed a fine of $28bn on Philip Morris, subsequently reduced by a factor of 1,000 to $28m.

Complacent

I wonder if investors are being unduly complacent. I don’t doubt the massive award will be cut. But it rested on an earlier ruling that litigants need only prove that a smoker was addicted to tobacco and that tobacco caused his or her death: it’s not necessary to establish any wrongdoing. That’s symptomatic of the tide of public opinion, which is turning fast against Big Tobacco.

Though there are still some areas of growth, the tobacco industry faces a structurally declining market. Thus consolidation, to maintain profits and cash flow, is the name of the game. It should drive dividend payments and M&A activity for some years yet.

E-cigarettes

Meanwhile the saviour of the industry could be e-cigarettes. However, they could also turn out to be the disruptive technology that accelerates the industry’s decline. With plain packing legislation reducing the value of brands and uncertainty over government and medical attitudes to e-cigarettes, it’s not certain that the new industry needs Big Tobacco. Why saddle yourself with those unquantifiable litigation liabilities?

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Tony Reading has no position in any shares mentioned. The Motley Fool has no position in any of the shares mentioned.

More on Investing Articles

Investing Articles

5 steps to start buying shares with under £500

Learn how this writer would start buying shares with a few hundred pounds in a handful of steps, if he…

Read more »

Young happy white woman loading groceries into the back of her car
Investing Articles

The FTSE 100 offers some great bargains. Is this one?

Our writer digs into one FTSE 100 share that has had a rough 2024 to date, ahead of its interim…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

£9,000 of savings? Here’s my 3-step approach to aim for £1,794 in passive income

Christopher Ruane walks through the practical steps he would take to try and turn £9,000 into a sizeable passive income…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

I’d buy 29,412 shares of this UK dividend stock for £150 a month in passive income

Insiders have been buying this dividend stock, which offers an 8.5% yield. Roland Head explains why he’d choose the shares…

Read more »

Red briefcase with the words Budget HM Treasury embossed in gold
Investing Articles

Could the new UK budget spell growth for these 6 FTSE stocks? I think so!

Mark David Hartley considers six UK stocks that could enjoy growth off the back of new measures announced in the…

Read more »

Investing Articles

With a 6.6% yield, is now the right time to add this income stock to my ISA?

Our writer’s looking to boost his Stocks and Shares ISA. With this in mind, he’s debating whether to buy a…

Read more »

Dividend Shares

This blue-chip FTSE stock just fell 12.5% in a day. Is it time to consider buying?

Smith & Nephew is a well-known, blue-chip FTSE stock with a decent dividend yield. And its share price just dropped…

Read more »

Investing Articles

At 72p, the Vodafone share price looks to be at least 33% undervalued to me

Our writer looks at a number of valuation measures to determine whether the Vodafone share price reflects the fair value…

Read more »